SCHEMBL27821229

SCHEMBL27821229

COc1nn(Cc2ccc(F)cc2)c2ccccc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 3/20 0.62
▸ CNR2 P34972 3/20 0.62
▸ ACHE P22303 1/20 0.56
▸ KDM4E B2RXH2 1/20 0.51
▸ GUCY1B2 O75343 1/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ CHRM2 P08172 1/20 0.51
▸ HTR1A P08908 1/20 0.51
▸ ADRA2A P08913 1/20 0.51
▸ CYP2D6 P10635 1/20 0.51
▸ CHRM1 P11229 1/20 0.51
▸ DRD1 P21728 1/20 0.51
▸ SLC6A2 P23975 1/20 0.51
▸ SLC6A4 P31645 1/20 0.51
▸ GUCY1A2 P33402 1/20 0.51
▸ ADRA1A P35348 1/20 0.51
▸ OPRM1 P35372 1/20 0.51
▸ DRD3 P35462 1/20 0.51
▸ SLC6A3 Q01959 1/20 0.51
▸ GUCY1A1 Q02108 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2760339 0.88 CNR2 (0.70) CNR1CNR2ACHEKDM4EGUCY1B2
SCHEMBL27923057 0.87 CNR2 (0.64) CNR1CNR2ACHEKDM4EGUCY1B2
SCHEMBL27821228 0.87 CNR2 (0.64) CNR1CNR2ACHEKDM4EGUCY1B2
SCHEMBL27800056 0.87 CNR2 (0.80) CNR1CNR2ACHEKDM4EGUCY1B2
SCHEMBL27941757 0.82 CNR1 (0.58) CNR1CNR2ACHEKDM4EGUCY1B2
SCHEMBL516738 0.81 CNR2 (0.67) CNR1CNR2ACHEKDM4EGUCY1B2
SCHEMBL27465301 0.81 SLC2A1 (0.55) CNR1CNR2ACHEKDM4EPOLB
SCHEMBL7818113 0.80 CNR1 (0.56) CNR1CNR2ACHEKDM4EGUCY1B2
SCHEMBL8808522 0.80 KDM4E (0.82) CNR1CNR2ACHEKDM4EGUCY1B2
SCHEMBL8415791 0.79 CNR1 (0.59) CNR1CNR2ACHEKDM4EGUCY1B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101965337-B Novel 1-benzil-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 ACRAF 2013-11-06 — — CN disclosed
CN-101965337-A Novel 1-benzil-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 ACRAF 2011-02-02 — — CN disclosed
CN-101945855-A Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 ACRAF 2011-01-12 — — CN disclosed
Send feedback